… colon [2,3]. This community has been linked to many diseases, including inflammatory bowel
disease … IBD encompasses a group of chronic inflammatory bowel pathologies of idiopathic …

… G Monteleone has filed a patent related to the treatment of inflammatory bowel diseases
with Smad7 antisense oligonucleotides and has served as an advisory board member for …

… JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for
multiple inflammatory cytokines. Am J Physiol Gastrointest Liver Physiol 2015; 310: G155–G162. …

… Inflammatory bowel disease (IBD) is a complex genetic disease that is instigated and
amplified by the confluence of multiple genetic and environmental variables that perturb the …

… intestinal tract inflammation, an anti-adhesion drug that prevents lymphocyte infiltration from
the blood into the inflamed gut, … the production of anti-inflammatory cytokines, as well as …

… advised by the International Organization for the Study of Inflammatory Bowel Disease include
… Stratification of inflammatory bowel disease risk of progression based on disease severity …

… that the microbiota is implicated in gut-related diseases such as inflammatory bowel disease
(IBD) and metabolic disorders 7,8,9,10 , as well as in diseases that affect other systems, …

… The burden of inflammatory bowel disease (IBD) is rising globally, with substantial variation
in levels and trends of disease in different countries and regions. Understanding these …

… need for personalised therapy come from? Inflammatory bowel diseases (IBD) consist of a
spectrum of several widely known disease phenotypes, including ulcerative colitis (UC) and …

… activities in inflammatory bowel diseases, demonstrating that the gut microbiome and the …
the host immune factors, are central to this disease [90]. Similarly, another recently published …